Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Ter Arkh ; 71(1): 31-4, 1999.
Artigo em Russo | MEDLINE | ID: mdl-10097297

RESUMO

AIM: Assessment of efficiency and safety of enalapril (enap) and its combination with hydrochlorotiaside (enap-N). MATERIALS AND METHODS: 127 patients with mild and moderate blood hypertension entered an open non-comparative multicenter trial. 60 of them received enap (group 1), 67--enap N (group 2). Group 1 patients were given enap for 2 weeks in a dose 10 mg/day. If this dose was not adequate to normalize blood pressure, it was raised to 20-40 mg/day. Patients of group 2 received enap-N one tablet a day for 3 weeks. If the pressure persisted higher than 140/90 mm Hg, the treatment was continued for 3 weeks more in a dose of 2 tablets a day. RESULTS: Blood pressure lowered under 140/90 mm Hg in 40 patients of group 1 (66.7%). Systolic pressure dropped by 10 mm Hg minimum and diastolic by 5 mm minimum in 18 group 1 patients (30%). Enap-N reduced blood pressure under 140-90 mm Hg in 44 of 67 patients (65.7%). Systolic and diastolic pressure dropped, respectively, in 23(34.3%) patients. CONCLUSION: Enap and enap-N tablets were found highly effective and well tolerated. Side effects were caused by lowering of blood pressure.


Assuntos
Inibidores da Enzima Conversora de Angiotensina/uso terapêutico , Enalapril/uso terapêutico , Hipertensão/tratamento farmacológico , Administração Oral , Adolescente , Adulto , Inibidores da Enzima Conversora de Angiotensina/administração & dosagem , Pressão Sanguínea/efeitos dos fármacos , Diuréticos , Quimioterapia Combinada , Enalapril/administração & dosagem , Seguimentos , Humanos , Hidroclorotiazida/administração & dosagem , Hidroclorotiazida/uso terapêutico , Hipertensão/diagnóstico , Hipertensão/fisiopatologia , Pessoa de Meia-Idade , Segurança , Índice de Gravidade de Doença , Inibidores de Simportadores de Cloreto de Sódio/administração & dosagem , Inibidores de Simportadores de Cloreto de Sódio/uso terapêutico , Resultado do Tratamento
2.
Lik Sprava ; (3): 163-5, 1998 May.
Artigo em Russo | MEDLINE | ID: mdl-9695602

RESUMO

Described in the article is one of the forms of optimization of the instructional process in the postgraduation physician training--"business-like games". Highly skilled, competent position of the teacher who conducts a business-like game secures an active participation in learning of students, helps in opening the mind, broadening the outlook on the problem under consideration, gives much incentive to further independent work on the discussed issues.


Assuntos
Educação Médica Continuada/métodos , Jogos Experimentais , Ensino/métodos , Diagnóstico Diferencial , Humanos , Resolução de Problemas , Ucrânia
5.
Kardiologiia ; 27(11): 68-72, 1987 Nov.
Artigo em Russo | MEDLINE | ID: mdl-3437668

RESUMO

The efficacy of nitrosorbide, corinfar and obsidan in preventing myocardial ischemia, induced by exercise or intravenous dipyridamole, was evaluated in 20 coronary patients. Nitrosorbide was found to be the most effective, and obsidan, the least effective, drug in preventing the steal syndrome. It is suggested that the efficiency of anti-anginal drugs is based on their effect on coronary flow control as well as hemodynamic determinants of myocardial oxygen requirements. The dipyridamole test can be used for the assessment of the effects of antianginal agents.


Assuntos
Doença das Coronárias/prevenção & controle , Dinitrato de Isossorbida/uso terapêutico , Nifedipino/uso terapêutico , Propranolol/uso terapêutico , Doença das Coronárias/induzido quimicamente , Dipiridamol , Teste de Esforço , Humanos , Masculino , Pessoa de Meia-Idade
6.
Kardiologiia ; 27(3): 29-33, 1987 Mar.
Artigo em Russo | MEDLINE | ID: mdl-3586479

RESUMO

Propranolol treatment for 6, 12 and 24 months was associated with a pronounced antianginal effect, both subjective and objective, in coronary patients, while the side effects rate was relatively small (3.3-7.3%). As the duration of treatment increases, the negative inotropic effect becomes less marked. Long-term propranolol treatment of coronary patients does not provoke any clinical signs of circulatory insufficiency. The treatment has the best effect in those coronary patients whose "double product" increases by more than 1.0 per 1 W of a standard 50 W load. The drug maximum antianginal effect is retained when this index drops below 1.0 in the course of two-week and six-month treatment.


Assuntos
Doença das Coronárias/tratamento farmacológico , Contração Miocárdica/efeitos dos fármacos , Propranolol/uso terapêutico , Doença das Coronárias/fisiopatologia , Teste de Esforço , Seguimentos , Humanos , Propranolol/farmacologia , Fatores de Tempo
9.
Ter Arkh ; 57(9): 34-7, 1985.
Artigo em Russo | MEDLINE | ID: mdl-4082046

RESUMO

A total of 64 patients with coronary heart disease were examined using contrast coronaro-ventriculography, veloergometry and estimation of the lactic acid level in the coronary sinus blood. Fifty-seven patients were referred to obsidan therapy by the "blind" method. Two groups of patients with asynergies of ischemic and cicatricial genesis were singled out. The sensitivity of the ST segment depression and sigma R increment as objective signs of ischemia significantly reduced in the presence of postinfarction cardiosclerosis. Obsidan monotherapy caused a rise of load power and volume of work performed in the patients with asynergies of ischemic origin: an antianginal effect of the drug in such cases was comparable to that in the patients without disturbed myocardial regional cantractility.


Assuntos
Doença das Coronárias/diagnóstico , Adulto , Angina Pectoris/diagnóstico , Angina Pectoris/fisiopatologia , Angiografia Coronária , Doença das Coronárias/tratamento farmacológico , Doença das Coronárias/fisiopatologia , Teste de Esforço , Ventrículos do Coração/diagnóstico por imagem , Humanos , Masculino , Pessoa de Meia-Idade , Propranolol/uso terapêutico
10.
Kardiologiia ; 24(6): 73-6, 1984 Jun.
Artigo em Russo | MEDLINE | ID: mdl-6748496

RESUMO

Using the blind method, a group of 91 coronary heart disease patients were studied. A two-week course of obsidan therapy proved to be most effective in patients with two impaired vessels and also in patients with a simultaneous decrease in the heart rate and in the systolic blood pressure during the threshold exercise. A parallel increase in the stroke index during exercise and a decrease in the myocardial contractile function at rest (by echocardiographic findings) suggest that the decrease in the systolic arterial pressure is associated with a negative inotropic effect of the drug. A decrease in the heart rate and myocardial contractility was observed only in patients with initial tachycardia and the intact functional state of the cardiac muscle. The best antianginal response occurs when these effects are combined.


Assuntos
Angina Pectoris/tratamento farmacológico , Propranolol/uso terapêutico , Angina Pectoris/fisiopatologia , Doença das Coronárias/tratamento farmacológico , Doença das Coronárias/fisiopatologia , Avaliação de Medicamentos , Ecocardiografia , Teste de Esforço , Hemodinâmica/efeitos dos fármacos , Humanos , Masculino , Pessoa de Meia-Idade , Placebos , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...